New combo treatments for alopecia areata: microneedling plus lactic acid, vitamin d, or steroid

NCT ID NCT06327581

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether microneedling combined with one of three substances—lactic acid, vitamin D3, or a steroid (triamcinolone acetonide)—can help regrow hair in people with patchy alopecia areata. Eighty-eight participants will receive one of the four treatments (including a saline control) over several sessions. The goal is to see which combination works best for hair regrowth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
lactic acid, vitamin D3, triamcinolone acetonide
What this could lead to
If successful, this could point toward a more effective, minimally invasive treatment option for patchy alopecia areata that combines microneedling with a topical agent.
What could go wrong
This is a small, early-phase comparative study (88 participants) with no blinding or placebo control, so results may not be conclusive. Side effects like skin irritation or atrophy are possible with the treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rana Ehab

    RECRUITING

    Zagazig, 44519, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.